At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses Patient Reported Opinions about Clinical Tolerability (PROACT), a mobile platform designed to enable patients to directly contribute to the understanding of an investigational agent in early clinical development.
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now